4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-025319
CEO and Director bought 9,692 shares at an average $2.56 ($24,771)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2022-09-06 | Purchase | +1,060 | $2.44 | $2,586 | 46,434 | D |
| Meckler Jeffrey A CEO and Director | 2022-09-07 | Purchase | +8,632 | $2.57 | $22,184 | 55,066 | D |
| Open-market purchases · 9,692 sh · avg $2.56 · $24,771 | |||||||
Loading xslF345X03/ownership.xml…